USPTO serial 75919453
Serial No. 75919453
Reviewed by CopyMark Law Group
Reg. 3130174Status 710
- Filing date
- Status date
- Registration date
- Aug 15, 2006
- Examiner
- SPRUILL, DARRYL M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 75919453?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
KIBBUTZ EINAT, 49910, IL
KIBBUTZ EINAT, 49910, IL
KIBBUTZ EINAT, 49910, IL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
WARREN A. SKIER
WARREN A SKIER RENNER, OTTO, BOISSELLE & SKLAR LLP1621 EUCLID AVE 19TH FLCLEVELAND, OH 44115UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical, pharmaceutical and health care products, namely, dermatologicals; medicated skin care preparations; adhesive bandages, containing pharmaceuticals for the treatment of-- rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples, saborrheic dermatitis for transdermal application and adhesive bandages for transdermally administering pharmaceutical preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; medical plasters impregnated with transdermally active pharmaceutical active preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; skin patches, for the transdermal delivery of pharmaceuticals, for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for application to the skin for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for medical purposes for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive skin patches for medical use for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive wound, burn and surgical dressings for application to the skin; adhesive wound, burn and surgical dressings for medical purposes; adhesive skin wound, burn and surgical dressings for medical use; wound, burn and surgical dressings incorporating a pharmaceutical preparation for application to the skin for the treatment of dermatological disorders, leg ulcers, pressure sores, lesions, skin grafts, carcinoma and scarring; adhesive medicated dressings incorporating a pharmaceutical preparation for application to the skin for the treatment of tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; wound, burn and surgical dressings for the transdermal delivery of pharmaceuticals for the treatment of tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; transdermal wound, burn and surgical dressings | SECTION 8 - CANCELLED | Sep 3, 2004 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 15, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 28, 2006 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jun 23, 2006 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2006 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 10, 2006 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 25, 2006 | IUAF | USE AMENDMENT FILED | — |
| May 25, 2006 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 17, 2006 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 20, 2005 | FAXX | FAX RECEIVED | — |
| Nov 29, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 16, 2005 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 16, 2005 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jan 11, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2003 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jun 30, 2003 | PAPER RECEIVED | — | |
| Jun 18, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 13, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 26, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2003 | PAPER RECEIVED | — | |
| Aug 29, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 28, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2000 | DOCK | ASSIGNED TO EXAMINER | — |